注射用丹参多酚酸钠治疗脑梗死的临床观察  

Clinical observation on treating cerebral infarction with the Danshen sodium polyphenol injection

作　　者：陈红东[1] 吴学永[1] 李春梅[1] 

机构地区：[1]高州市人民医院,广东高州525200

出　　处：《中医临床研究》2016年第5期8-9,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:观察注射用丹参多酚酸钠治疗脑梗死的临床疗效。方法:以我院2013年10月-2014年10月收治的70例脑梗死患者为研究对象,随机将其分为两组,各35例,对照组患者采取常规治疗,观察组患者在对照组基础上行注射用丹参多酚酸钠治疗,比较两组临床疗效、不良反应、治疗前后CRP、FIB、NIHSS评分及Barthel指数。结果:观察组总有效率为91.4%,与对照组的71.4%比较,差异显著(P<0.05)。两组治疗后NIHSS评分、Barthel指数、CRP、FIB比较差异显著(P<0.05)。另外,两组均未发生明显不良反应。结论:注射用丹参多酚酸钠能有效降低患者血浆黏度及炎症反应,促进缺损神经功能恢复,提高患者日常生活活动能力,值得临床推广。Objective： To investigate clinical effects of the Danshen sodium polyphenol injection on cerebral infarction. Methods： 70 patients were randomly divided into two groups, each 35; the control group took conventional therapy; the observation group took the Dansen sodium polyphenol injection; clinical efficacy, adverse reactions, CRP, FIB, NIHSS score and Barthel index were recorded. Results： The total efficiency in the observation group was 91.4%, better than 71.4% in the control group（P〈0.05）. After treatment, the NIHSS, Barthel index, CRP, FIB showed significant difference（P〈0.05）. Conclusion： The Danshen sodium polyphenols injection can reduce plasma viscosity and inflammation, promote recovery of neurological function, and is worthy of promotion.

关 键 词：注射用丹参多酚酸钠 脑梗死 NIHSS评分 疗效 

分 类 号：R743.32[医药卫生—神经病学与精神病学]